维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Zimmerhackl"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab 显示文摘	Kose O Zimmerhackl LB Jungraithmayr T	2010	Semin Thromb Hemost2010，36，6：	1
2	Prevention and treatment of enterohemorrhagic Escherichia coli infections in humans显示文摘	Orth D Grif K Zimmerhackl LB	2008	Expert Rev Anti Infect Ther2008，6，1：	1
3	New treat-ment Options for atypical hemolytic uremic syndrome with thecomplement inhibitor eculizumab显示文摘	Kose O Zimmerhackl LB Jungraithmayr T	2010	Semin Thromb Hemost2010，36，6：	1
4	Increased urinary excretion of tubular enzymes and proteins in children with epilepsy 显示文摘	Korinthenberg R Sager J Zimmerhackl LB	2000	Eur J Paediatr Neurol2000，4，6：	1
5	Today's understanding of thehaemolytic uraemic syndrome显示文摘	Scheiring J Rosales A Zimmerhackl LB	2010	Eur J Pediatr2010，169，1：	1
6	Complete remission of post - transplant FSGS recurrence by long - term plasmapheresis 显示文摘	Haffner K Zimmerhackl LB yon Schnakenburg C	2005	Pediatr Nephrol2005，20，7：	1
7	The selective adhesion molecule inhibitor Natalizumab deereases multiple myeloma cell growth inthe bone marrow microenvironment: therapcutie implications 显示文摘	Podar K Zimmerhackl A Fulciniti M	2011	Br J Haematol2011，155，4：	1
8	New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab 显示文摘	Kose O Zimmerhackl LB Jungraithmayr T	2010	Semin Thromb Hemost2010，36，6：	1
9	Rituximab in child-hood systemic lupus erythematosus refractory to conventional immuno-suppression显示文摘	Edelbauer M Jungraithmayr T Zimmerhackl LB		0，，：	1
10	Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H显示文摘	Riedl M Rosales A Zimmerhackl LB		0，，03：	1
11	The se-lective adhesion molecule inhibitor Natalizumab decreases multi-ple myeloma cell growth in the bone marrow microenvironment:therapeutic implications显示文摘	PODAR K ZIMMERHACKL A FULCINITI M	2011	British Journal of Haematology2011，155，4：	1
12	Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)显示文摘	Scheiring J Andreoli SP Zimmerhackl LB		0，，10：	1
13	Hemolytic uremic syndrome in childhood显示文摘	Gordjani N Sutor AH Zimmerhackl LB	1997	Semin Thromb Hemost1997，23，3：	1
14	Prevention and Treatment of Entemhemorrhagic Escherichia Coli Infections in Humans显示文摘	Orth D Grif K Zimmerhackl L B	2008	Expert Rev Anti Infect2008，6，1：	1
15	Influence of systemically applied angiotensin Ⅱ on the microcirculation of glomerular capillaries in the rat显示文摘	Zimmerhackl B Parekh N Kücherer H	1985	Kidney Int1985，27，1：	1
16	Prophylactic eculizum- ab after renal transplantation in atypical hemolytic-uremic syndrome 显示文摘	Zimmerhackl LB Hofer J Cortina G	2010	N Engl J Med2010，362，18：	1
17	Treatment and outcome of shiga toxin associated hemolytic uremic syndrome (HUS) 显示文摘	Scheiring J Andreoli SP Zimmerhackl LB	2008	Pediatr Nephrol2008，23，：	1
18	New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab显示文摘	Kose O Zimmerhackl LB Jungraithmayr T	2010	Semin Thromb Hemost2010，36，：	1
19	Renal excretion of endothelin in children显示文摘	Mattyus I Zimmerhackl LB Schwarz A	1997	Pediatr Nephrol1997，11，4：	1
20	Myfortic in pediatric transplantation显示文摘	Zimmerhackl LB Jungraithmayr T Wiesmayr S	2008	Pediatr Transplant2008，12，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示